Clinical Trial Update: A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and Insomnia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating co-administration of eszopiclone with venlafaxine for major depressive disorder with insomnia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Major Depressive Disorder

Drugs mentioned

• Effexor (venlafaxine)
• Lunesta (eszopiclone)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Major Depressive Disorder, Insomnia | Phase 3 | Status: COMPLETED